R1	Has_value Arg1:T2 Arg2:T3	
R2	Subsumes Arg1:T4 Arg2:T2	
R3	Has_qualifier Arg1:T1 Arg2:T4	
*	OR T7 T8
R4	AND Arg1:T6 Arg2:T7	
R5	Has_qualifier Arg1:T10 Arg2:T11	
*	OR T10 T6
R6	Has_qualifier Arg1:T13 Arg2:T14	
R7	Has_qualifier Arg1:T19 Arg2:T18	
R8	Has_qualifier Arg1:T19 Arg2:T17	
*	OR T15 T16 T19
R9	Has_temporal Arg1:T15 Arg2:T20	
*	OR T23 T24
R10	Has_qualifier Arg1:T23 Arg2:T22	
R11	Has_mood Arg1:T23 Arg2:T26	
R12	Subsumes Arg1:T13 Arg2:T15	
R13	Has_qualifier Arg1:T28 Arg2:T29	
*	OR T30 T31
R14	Has_qualifier Arg1:T31 Arg2:T32	
R15	AND Arg1:T37 Arg2:T38	
R16	Has_qualifier Arg1:T34 Arg2:T33	
*	OR T34 T35 T36 T37
*	OR T40 T41
R17	Has_temporal Arg1:T39 Arg2:T40	
R18	Has_value Arg1:T45 Arg2:T46	
R19	Has_value Arg1:T47 Arg2:T48	
R20	Has_value Arg1:T50 Arg2:T51	
*	OR T50 T45
R21	Subsumes Arg1:T49 Arg2:T50	
R22	Subsumes Arg1:T44 Arg2:T47	
*	OR T44 T49
R23	AND Arg1:T54 Arg2:T53	
R24	Has_temporal Arg1:T55 Arg2:T56	
R25	Has_value Arg1:T57 Arg2:T58	
R26	Has_qualifier Arg1:T64 Arg2:T65	
*	OR T59 T61 T62 T63 T64 T60
R27	AND Arg1:T58 Arg2:T59	
T1	Condition 6 10	pain
T2	Measurement 34 42	duration
T3	Value 12 30	less than 3 months
T4	Qualifier 0 5	Acute
T6	Condition 79 95	hypersensitivity
T7	Drug 99 107	cannabis
T8	Drug 111 123	cannabinoids
T10	Condition 62 75	adverse event
T11	Qualifier 54 61	serious
T12	Non-query-able 125 194	Inability to understand and comply with the instructions of the study
T13	Condition 220 235	cardiac disease
T14	Qualifier 208 219	significant
T15	Condition 248 279	unstable ischemic heart disease
T16	Condition 281 294	heart failure
T17	Qualifier 296 302	severe
T18	Qualifier 307 319	uncontrolled
T19	Condition 320 332	hypertension
T20	Temporal 237 244	history
T22	Qualifier 411 433	clinically significant
T23	Condition 434 444	arrhythmia
T24	Condition 448 469	myocardial infarction
T26	Mood 398 408	at risk of
T28	Condition 479 501	substance use disorder
T29	Qualifier 519 594	Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5)
T30	Condition 617 639	dependence on cannabis
T31	Condition 656 683	cannabis use disorder (CUD)
T32	Qualifier 701 706	DSM 5
T33	Qualifier 729 734	DSM 5
T34	Condition 735 748	schizophrenia
T35	Condition 750 766	bipolar disorder
T36	Condition 780 789	psychosis
T37	Condition 798 809	intolerance
T38	Drug 813 825	cannabinoids
T39	Condition 849 866	suicidal ideation
T40	Temporal 827 834	Current
T41	Temporal 838 845	history
T43	Pregnancy_considerations 868 1081	Pregnant, breast-feeding or female patients of child-bearing potential and male patients whose partner is of child-bearing potential, unless willing to ensure that they or their partner use effective contraception
T44	Condition 1083 1101	Hepatic impairment
T45	Measurement 1226 1269	Estimated Glomerular Filtration Rate (eGFR)
T46	Value 1270 1273	<60
T47	Measurement 1103 1129	aspartate aminotransferase
T48	Value 1130 1158	more than three times normal
T49	Condition 1163 1188	renal function impairment
T50	Measurement 1190 1212	serum creatinine level
T51	Value 1213 1224	>133 Âµmol/L
T53	Condition 1276 1296	Cognitive impairment
T54	Procedure 1310 1317	MiniCog
T55	Drug 1362 1391	cannabinoid based medications
T56	Temporal 1392 1421	within 90 days of study entry
T57	Measurement 1490 1507	urine drug screen
T58	Value 1481 1489	Positive
T59	Drug 1512 1524	cannabinoids
T60	Drug 1568 1575	alcohol
T61	Drug 1577 1584	cocaine
T62	Drug 1586 1598	amphetamines
T63	Drug 1603 1619	methamphetamines
T64	Drug 1634 1641	opioids
T65	Qualifier 1621 1633	unprescribed
T67	Competing_trial 1644 1724	Participation in another clinical trial within 30 days of enrolment in our trial
